Radiant is designed for use in chimney endovascular aneurysm repair (ChEVAR) with the Endurant II/IIs stent graft system. It maintains perfusion to renal arteries when used in combination with the stent graft.
The medtech giant said that Radiant is the first and only covered stent indicated for such use. It comes from a long-term collaboration between Medtronic and Getinge. The platform leverages Getinge’s Advanta V12 balloon expandable covered stent design.
Radiant and Endurant II/IIs combine to offer a standardized, on-label, off-the-shelf solution for short-neck, juxtarenal abdominal aortic aneurysms (AAA). Medtronic said this enables safe and effective endovascular repair in both urgent and elective juxtarenal AAA cases.
The platform offers predictable, accurate delivery and deployment along with flexibility and radial strength. Medtronic said it demonstrated better mid-term patency performance in ChEVAR compared to other covered stents.
Medtronic plans to roll out a comprehensive training program and invest in clinical data for the platform. It intends to make the system commercially available in Western Europe in November 2022. The company expects other regions recognizing CE Mark to follow in 2023.
“I can’t wait to get this product into the field and, ultimately, to the physicians and patients we innovate for every day,” said Carolyn Sleeth, VP and GM of Medtronic’s Aortic operating unit.
Medtronic leverages Getinge’s proven quality
In a separate release, Getinge said Medtronic chose to collaborate with the company because of the proven performance of Advanta V12.
Getinge plans to manufacture Radiant for Medtronic beginning in the fourth quarter of 2022.
“This important collaboration provides clinicians with a package solution for complex aortic repair,” said Patty Burns, senior director, global marketing and product management, vascular systems at Getinge. “To support this business expansion, Getinge has invested in doubling our stent production capacity in order to provide all of our global customers with the devices needed to treat patients.”
